Navigation menu Search
  • Home
  • About
  • CEME Facts CEME Facts
    • What is CEME?
    • How does CEME work?
    • Why is CEME valuable?
  • Results Results
    • Clients & Testimonials
    • Case studies
  • News
  • Contact
  • Back to top

McCormack Pharma


Call on :

  • New teachings mean new life
  • New teachings mean new directions
  • New teachings mean new IP
  • New teachings mean new methods
  • New teachings mean new sales

McCormack Pharma sends press release regarding clopidogrel breakthrough to news agencies

24th November, 2014

The first press release to be sent out under McCormack Pharma’s new distribution systems has now been formally released to agencies worldwide.

The officially-distributed release, which deals with the company’s recent breakthrough discovery on clopidogrel resistance, was handled by eReleases and can be viewed at PR Newswire and PressReleaseHeadlines.com, or here on this site.

  • Previous news item
  • Next news item

Site snapshot

Case studies

  1. Azapropazone (A H Robins; Wyeth)
  2. Clopidogrel (GSK)
  3. Captopril (GSK)
  4. Ketoprofen (Rhone-Poulenc Rorer (RPR))
  5. Buprenorphine (Reckitt & Colman )
  6. View all

News articles

  1. CEME: When a drug’s intracellular footprint doesn’t add up
  2. Dexrazoxane — a smart drug that breaks all the rules
  3. CEME – a purpose-built tool for value-differentiation
  4. CEME - fidelity and precision in gathering and sorting real world data
  5. 40 year-old drug may be preferred choice for post-acute myocardial infarction patients
  6. View all

Press releases

  1. The Deterministic Quasi-Chaos Of Pharma’s Big Data: Me-too drugs and the butterfly effect
  2. McCormack Pharma’s landmark discovery could mean new guidelines for use of anti-platelet drug
  3. McCormack Pharma announces a breakthrough discovery in the mechanism of clopidogrel resistance
  4. View all

Testimonials

  1. Clinigen Group plc
  2. Nycomed
  3. GlaxoSmithKline plc
  4. Javelin Pharmaceuticals
  5. Eisai Europe Ltd
  6. View all

© 2014-2025 McCormack Limited

McCormack Pharma is a trading name of McCormack Limited

Information regarding cookies & data privacy

Web design by Rick Lecoat

  • Home
  • About
  • CEME Facts CEME Facts
    • What is CEME?
    • How does CEME work?
    • Why is CEME valuable?
  • Results Results
    • Clients & Testimonials
    • Case studies
  • News
  • Contact
  • Back to top